Medical Education for doctors
Cambridge, England
Joined August 2013
- Tweets144
- Following101
- Followers60
- Likes114
CambMedicalSeminars retweeted
The next frontier for prevention of heart and vascular disease isn't targeting lipids. It's about blocking inflammation. These are some of the ongoing clinical trials @NatureMedicine
nature.com/articles/d41591-0…
CambMedicalSeminars retweeted
The Shingles vaccine has outperformed all expectations. Why?
erictopol.substack.com/p/spo…
Potential therapy for heart attacks?
Read about the Phase 2 IVORY trial and patient experiences of clinical research @CambridgeIndy
@Cambridge_Uni
@CUH_NHS
@RoyalPapworth
@NatureMedicine
Open access paper:
nature.com/articles/s41591-0…
Reducing inflammation by upregulat8ng Tregs could be beneficial post MI
#heartattack @TheBHF
@Cambridge_Uni
@CUH_NHS
nature.com/articles/s41591-0…
In a randomized phase 2 trial in patients with acute #coronary syndrome and high levels of the inflammation #biomarker CRP, treatment with low-dose interleukin-2 increased the numbers of regulatory T cells and reduced arterial #inflammation, as compared to placebo.
nature.com/articles/s41591-0…
Paper available here
nature.com/articles/s41591-0…
linkedin.com/posts/cambridge…
Repurposed drug reduces vascular inflammation post MI and may reduce recurrent events nature.com/articles/s41591-0…
CambMedicalSeminars retweeted
IVORY trial: Maintenance of immune tolerance by ⬆️Tregs important in inflamed post-heart attack subjects ICYMI #NobelPrize 2025 Medicine @ZMallat @rouchelle45 @TheBHF @CUH_NHS @Cambridge_Uni @The_MRC @BBC @TheTelegraph__ @thetimes @ehj_ed @TomLuscher @NatureMedicine @NEJM
After 6 weeks of Rx patients with ACSs, low-dose IL-2 safely increases Tregcell levels and reduces arterial inflammation.
nature.com/articles/s41591-0…
CambMedicalSeminars retweeted
After 6 weeks of Rx patients with ACSs, low-dose IL-2 safely increases Tregcell levels and reduces arterial inflammation.
nature.com/articles/s41591-0…
CambMedicalSeminars retweeted
Blocking artery inflammation and increasing Treg cells in a small randomized trial with low-dose interleukin-2
nature.com/articles/s41591-0…
Dr Pauls @mathildepauls provided an update on managing acute stroke including presentation modes, methods of assessment, and up-to-date pharmacotherapies and interventions @Cambridge_Uni @CUH_NHS
Practical clues to sorting out the acute hot joint by Dr Nick Shenker @Cambridge_Uni @CUH_NHS
Dr Tony Coll provide a practical and important talk on managing diabetic emergencies
@Cambridge_Uni @CUH_NHS
Managing acute kidney injury and hyperkalemia expertly in secondary care - Dr Andy Fry @AndyFry101 going through a step by step approach in expertly managing this important emergency
@Cambridge_Uni @CUH_NHS
Dr Lisa Sharkey @lisa_shark going through a fantastic update of endoscopic techniques to treat multiple GI conditions from clips to sleeves and numerous pharmacotherapeutic advances in the gastro world
@Cambridge_Uni @CUH_NHS
Dr Ravi Mahadeva provided a thorough review of COPD in 2023, reminiscing the changes since the first CMS he presented at 16 years ago! @Cambridge_Uni @CUH_NHS
Dr @GregMellor7 provided a entertaining quiz on a myriad of ECGs - with the winner picking up a special prize! @Cambridge_Uni @CUH_NHS
Dr Victoria Snowdon provided an erudite overview of cirrhosis and liver cancer
@CUH_NHS @Cambridge_Uni @SunwayMedical @SunwayU @RCPhysicians
Dr Chung Yun Chien gave an in-depth review of NAFLD should be redefined as MAFLD
@SunwayMedical @SunwayU @RCPhysicians @Cambridge_Uni
Dr Laura Jopson gave a fantastic overview of investigating liver disease
@RCPhysicians @SunwayMedical @SunwayU
